Websites Selling Direct-to-Consumer Anti-Mullerian Hormone Tests

Authors:

Abstract
The average age of mothers at first birth is increasing in high-income countries,1 in part explained by the rise of effective contraception, increases in women’s education and labor market participation, value changes, gender equity, and partnership changes.2 As female fertility decreases with advancing age, this increases the risk and prevalence of involuntary childlessness.3 Over the past decade, there has been growing attention in both the media and in academic literature around the anti-Mullerian hormone (AMH) test (often nicknamed the egg timer test),4,5 with some clinicians and researchers suggesting routine screening to increase reproductive awareness and the chance of parenthood in women with accelerated ovarian aging.6 AMH is produced by the granulosa cells in the ovarian follicles.7 AMH levels in the blood correspond to the number of antral follicles in the ovaries and is used to estimate ovarian reserve.8,9 Although AMH testing is useful in the context of fertility treatment, as it indicates the number of eggs that can be retrieved in a stimulated cycle for in vitro fertilization (IVF) or egg freezing,10 AMH is not a reliable measure of fertility. However, recent introduction of direct-to-consumer (DTC) AMH testing in several countries4,11,12 has expanded public access to the test and provided a pathway to testing without the involvement of or counseling from an independent health care practitioner.

This publication has 44 references indexed in Scilit: